AMD in Action: Fighting Infectious Disease on Many Fronts | Advanced Molecular Detection (AMD) | CDC
Exploring meningococcal outbreaks and carriage with whole genome sequencing
Vaccination is the best defense against meningococcal disease. In late 2014 and early 2015, FDA approved new vaccines to help protect against a fifth type of the bacteria that causes the disease, Neisseria meningitidis serogroup B. Soon after in 2015, two universities on opposite sides of the country experienced outbreaks of serogroup B meningococcal disease. This provided a chance to use AMD to examine the impact these new vaccines have on carriage of N. meningitidis.
No hay comentarios:
Publicar un comentario